Return on Equity (ROE)
Updated 80h ago
Sector Performance
45th percentileTXT
12.3%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
Return on Equity (ROE) measures how efficiently a company generates profit from shareholders' money: a 12.3% ROE means TXT earns $12.30 in net income for every $100 of equity.
This is below the sector median of 13.7%, placing TXT in the 45th percentile among its peers — meaning it performs worse than 55% of comparable companies. No trend data is available: year-over-year change is N/A and quarter-over-quarter change is N/A, so there is no basis to assess whether ROE is improving or deteriorating. The combination of a ROE below the sector median and a complete absence of trend information offers little insight into future performance, making the metric a neutral signal for risk or opportunity. This directly supports the overall NEUTRAL verdict, as the current level is slightly underwhelming but not alarming, and the lack of trend data prevents any directional bias.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about TXT?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are TXT's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master TXT's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full TXT research report →TXT
12.3%
Sector Median
13.8%
Sector Avg
31.4%
How TXT's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.